Position in KRYS
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,769,149
+$431,827 QoQ
Shares Held
4,760
-8.1% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#169
of 416 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KRYS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ProShare Advisors LLC holds $336,287,535 across 174 Biotechnology names. KRYS ranks #8 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
287,847 | $142,982,240 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
119,240 | $74,350,909 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
128,514 | $38,686,569 | |
| 4 | INCY |
Incyte Corp
|
48,152 | $5,458,510 | |
| 5 | MRNA |
Moderna, Inc.
|
70,621 | $4,945,588 | |
| 6 | CYTK |
Cytokinetics Inc
|
27,121 | $2,310,437 | |
| 7 | TECH |
BIO-TECHNE Corp
|
30,597 | $2,161,678 | |
| 8 | KRYS |
Krystal Biotech, Inc.
This page
|
4,760 | $1,769,149 |
All Filings in KRYS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,769,149 | 4,760 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $1,337,322 | 5,177 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $1,507,838 | 6,116 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $1,009,222 | 5,717 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $910,672 | 6,625 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $1,289,325 | 7,151 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $1,386,127 | 8,848 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,252,548 | 6,881 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $946,480 | 5,154 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,043,559 | 5,865 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $667,318 | 5,379 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $538,124 | 4,639 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $526,069 | 4,481 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $343,937 | 4,296 | Shares | Sole | 2023-05-26 | |
| 2022-12-31 | $386,039 | 4,873 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $314,416 | 4,511 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $285,621 | 4,350 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $424,392 | 6,378 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $492,867 | 7,046 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $367,610 | 7,041 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $587,588 | 8,641 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $543,902 | 7,060 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $362,280 | 6,038 | Shares | Sole | 2021-02-09 | |
| No filing history on record for this holder in this stock. | ||||||